[
1. Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer 2009; 115: 1531-43.10.1002/cncr.24121281320719197972
]Search in Google Scholar
[
2. Ritter J, Bielack SS. Osteosarcoma. Ann Oncol 2010; 21: 320-5.10.1093/annonc/mdq27620943636
]Search in Google Scholar
[
3. Arndt CA, Crist WM. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 1999; 341: 342-52.10.1056/NEJM19990729341050710423470
]Search in Google Scholar
[
4. Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002; 20: 776-90.10.1200/JCO.2002.20.3.77611821461
]Search in Google Scholar
[
5. Bielack S, Jürgens H, Jundt G, Kevric M, Kühne T, Reichardt P, et al. Osteosarcoma: the COSS experience. Cancer Treat Res 2009; 152: 289-308.10.1007/978-1-4419-0284-9_1520213397
]Search in Google Scholar
[
6. Bacci G, Rocca M, Salone M, Balladelli A, Ferrari S, Palmerini E, et al. High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. J Surg Oncol 2008; 98: 415-20.10.1002/jso.2114018792969
]Search in Google Scholar
[
7. Bielack SS, Carrle D, Hardes J, Schuck A, Paulussen M. Bone tumors in adolescents and young adults. Curr Treat Options Oncol 2008; 9: 67-80.10.1007/s11864-008-0057-118449804
]Search in Google Scholar
[
8. Messerschmitt PJ, Garcia RM, Abdul-Karim FW, Greenfield EM, Getty PJ. Osteosarcoma. J Am Acad Orthop Surg 2009; 17: 515-27.10.5435/00124635-200908000-0000519652033
]Search in Google Scholar
[
9. Kager L, Zoubek A, Pötschger U, Kastner U, Flege S, Kempf-Bielack B, et al. Cooperative German-Austrian-Swiss Osteosarcoma Study Group. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J ClinOncol 2003; 21: 2011-8.10.1200/JCO.2003.08.13212743156
]Search in Google Scholar
[
10. Posthuma De Boer J, Witlox MA, Kaspers GJ, van Royen BJ. Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature. Clin Exp Metastasis 2011; 28: 493-503.10.1007/s10585-011-9384-x308105821461590
]Search in Google Scholar
[
11. Kim DH, Kim SY, Lee HJ, Song BS, Kim DH, Cho JB, et al. Assessment of Chemotherapy Response Using FDG-PET in Pediatric Bone Tumors: A Single Institution Experience. Cancer Res Treat 2011; 43: 170-5.10.4143/crt.2011.43.3.170319287822022294
]Search in Google Scholar
[
12. Wuisman P, Enneking WF. Prognosis for patients who have osteosarcoma with skip metastasis. J Bone Joint Surg Am 1990; 72: 60-8.10.2106/00004623-199072010-00010
]Search in Google Scholar
[
13. Xu J, Shen J, Ding Y, Shen HY, Zeng ZP, Ma RF, et al. The clinical value of combined use of MR imaging and multi-slice spiral CT in limb salvage surgery for orthopaedic oncology patients: initial experience in nine patients. RadiolOncol 2012; 46: 189-97.10.2478/v10019-012-0020-4347294323077457
]Search in Google Scholar
[
14. Chen J, Zhao Y, Li X, Sun P, Wang M, Wang R, et al. Imaging primary prostate cancer with 11C-Choline PET-CT: relation to tumour stage, Gleason score and biomarkers of biologic aggressiveness. Radiol Oncol 2012; 46: 179-88.10.2478/v10019-012-0034-y347294423077456
]Search in Google Scholar
[
15. Kim JS, Jeong YJ, Sohn MH, Jeong HJ, Lim ST, Kim DW, et al. Usefulness of F-18 FDG PET/CT in subcutaneous panniculitis-like T cell lymphoma: disease extent and treatment response evaluation. Radiol Oncol 2012; 46: 279-83.10.2478/v10019-012-0017-z357289123412422
]Search in Google Scholar
[
16. Lakkaraju A, Patel CN, Bradley KM, Scarsbrook AF. PET/CT in primary musculoskeletal tumours: a step forward. Eur Radiol 2010; 20: 2959-72.10.1007/s00330-010-1862-z20577880
]Search in Google Scholar
[
17. Treglia G, Cason E, Fagioli G. Recent applications of nuclear medicine in diagnostics (first part). Ital J Med. 2010; 4: 84-91.10.1016/j.itjm.2010.03.001
]Search in Google Scholar
[
18. Treglia G, Salsano M, Stefanelli A, Mattoli MV, Giordano A, Bonomo L. Diagnostic accuracy of 18F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis. SkeletalRadiol 2012; 41: 249-56.
]Search in Google Scholar
[
19. Schulte M, Brecht-Krauss D, Heymer B, Guhlmann A, Hartwig E, Sarkar MR, et al. Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. J Nucl Med 2000; 41: 1695-701.
]Search in Google Scholar
[
20. Kneisl JS, Patt JC, Johnson JC, Zuger JH. Is PET useful in detecting occult nonpulmonary metastases in pediatric bone sarcomas? Clin Orthop RelatRes 2006; 450: 101-4.
]Search in Google Scholar
[
21. Charest M, Hickeson M, Lisbona R, Novales-Diaz JA, Derbekyan V, Turcotte RE. FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases. Eur J Nucl Med Mol Imaging 2009; 36: 1944-51.10.1007/s00259-009-1203-019593561
]Search in Google Scholar
[
22. Fuglø HM, Jørgensen SM, Loft A, Hovgaard D, Petersen MM. The diagnostic and prognostic value of 18F-FDG PET/CT in the initial assessment of highgrade bone and soft-tissue sarcoma. A retrospective study of 89 patients. Eur J Nucl Med Mol Imaging 2012; 39: 1416-24.10.1007/s00259-012-2159-z22699526
]Search in Google Scholar
[
23. Garcia R, Kim EE, Wong FC, Korkmaz M, Wong WH, Yang DJ, et al. Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas. J Nucl Med 1996; 37: 1476-9.
]Search in Google Scholar
[
24. Völker T, Denecke T, Steffen I, Misch D, Schönberger S, Plotkin M, et al. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol 2007; 25: 5435-41.10.1200/JCO.2007.12.247318048826
]Search in Google Scholar
[
25. Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Kim EE. Bone and softtissue sarcoma: preoperative staging with fluorine 18 fluorodeoxyglucose PET/CT and conventional imaging. Radiology 2007; 245: 839-47.10.1148/radiol.245306153818024454
]Search in Google Scholar
[
26. Piperkova E, Mikhaeil M, Mousavi A, Libes R, Viejo-Rullan F, Lin H. Impact of PET and CT in PET/CT studies for staging and evaluating treatment response in bone and soft tissue sarcomas. Clin Nucl Med 2009; 34: 146-50.10.1097/RLU.0b013e3181966f9d19352275
]Search in Google Scholar
[
27. London K, Stege C, Cross S, Onikul E, Graf N, Kaspers G, et al. 18F-FDG PET/ CT compared to conventional imaging modalities in pediatric primary bone tumors. Pediatr Radiol 2012; 42: 418-30.10.1007/s00247-011-2278-x22134535
]Search in Google Scholar
[
28. Bandopadhyaya GP, Gupta P, Singh A, Shukla J, Rastogi S, Kumar R, et al. (99m)Tc-DMSA (V) in evaluation of osteosarcoma: comparative studies with (18)F-FDG PET/CT in detection of primary and malignant lesions. ISRNOncol. 2012; 2012: 371830.
]Search in Google Scholar
[
29. Franzius C, Daldrup-Link HE, Sciuk J, Rummeny EJ, Bielack S, Jürgens H, et al. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Ann Oncol 2001; 12: 479-86.10.1023/A:1011111322376
]Search in Google Scholar
[
30. Iagaru A, Chawla S, Menendez L, Conti PS. 18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas. NuclMed Commun 2006; 27: 795-802.10.1097/01.mnm.0000237986.31597.8616969262
]Search in Google Scholar
[
31. Cistaro A, Lopci E, Gastaldo L, Fania P, Brach Del Prever A, et al. The role of (18) F-FDG PET/CT in the metabolic characterization of lung nodules in pediatric patients with bone sarcoma. Pediatr Blood Cancer. 2012; 59: 1206-10.10.1002/pbc.2424222745027
]Search in Google Scholar